Kinetotoxic Mechanisms of Environmental Carcinogens
环境致癌物的运动毒性机制
基本信息
- 批准号:7013572
- 负责人:
- 金额:$ 29.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-05 至 2008-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Several different in vitro and ex vivo-derived rodent cell lines were developed that recapitulate the specialized asymmetric cell kinetics of adult somatic tissue stem cells in vivo. Previously, these model cells have been used to investigate and define genetic and molecular mechanisms that control adult stem cell kinetics. In the proposed research, the model cells will be used to investigate whether environmental agents, that are known to induce human cancers but with no detectable mutagenic activity, do so by disrupting adult stem cell kinetics. Specifically, the hypothesis that some non-mutagenic carcinogens function by inducing increased rates of stem cell proliferation will be examined. Disruption of asymmetric stem cell kinetics is an essential step in human carcinogenesis. "Kinetotoxic" effects by environmental contaminants, that lead to increased adult stem cell proliferation, may also be important in the etiology of other chronic processes associated with altered cell proliferation (e.g., premature aging). The model cells have already been used to identify 3 organic compounds that switch exposed cells from asymmetric cell kinetics to exponential cell kinetics. The main focus of the proposed research will be to use these cell lines to evaluate well established non-mutagenic environmental carcinogens for kinetotoxicity. Both acute high-dose and chronic low-dose exposures will be investigated. In addition to evaluating non-mutagenic compounds, several well-known mutagenic carcinogens will be examined, as they may exhibit concurrent kinetotoxicity. Chemicals found to induce changes in cell kinetics will be evaluated for molecular effects on cellular genes previously identified as regulators of asymmetric cell kinetics. In preliminary studies, the IARC Group 1 human carcinogen benzene exhibits evidence for kinetotoxicity. Benzene has a well-documented history as a potent non-mutagenic human carcinogen. It will serve as the prototype kinetotoxic agent for developing a systematic approach to revealing kinetotoxic mechanisms. In vitro human cell lines with asymmetric cell kinetics will be derived to provide kinetotoxicity assays that may have greater relevance to human adult stem cell physiology. The proposed research has the goal of providing new insights to the carcinogenic mechanisms of well studied environmental contaminants whose mode of action remains a mystery. Such insights will advance efforts to develop better strategies to limit morbidity associated with exposure to environmental carcinogens.
描述(由申请人提供):开发了几种不同的体外和离体衍生的啮齿动物细胞系,它们概括了体内成体组织干细胞的专门不对称细胞动力学。此前,这些模型细胞已被用来研究和定义控制成体干细胞动力学的遗传和分子机制。在拟议的研究中,模型细胞将用于研究环境因素是否通过破坏成体干细胞动力学来诱导人类癌症,但没有可检测到的诱变活性。具体来说,将检验一些非诱变致癌物通过诱导干细胞增殖率增加而发挥作用的假设。不对称干细胞动力学的破坏是人类致癌的重要步骤。环境污染物的“运动毒性”效应会导致成体干细胞增殖增加,这在与细胞增殖改变(例如过早衰老)相关的其他慢性过程的病因学中也可能很重要。模型细胞已用于识别 3 种有机化合物,这些化合物可将暴露的细胞从不对称细胞动力学转变为指数细胞动力学。拟议研究的主要重点将是使用这些细胞系来评估已确定的非致突变环境致癌物的运动毒性。急性高剂量和慢性低剂量暴露都将受到调查。除了评估非诱变化合物外,还将检查几种众所周知的诱变致癌物,因为它们可能表现出并发的运动毒性。将评估被发现诱导细胞动力学变化的化学物质对先前被确定为不对称细胞动力学调节剂的细胞基因的分子影响。在初步研究中,IARC 第 1 类人类致癌物苯显示出具有运动毒性的证据。苯作为一种有效的非致突变性人类致癌物有着充分的历史记录。它将作为原型运动毒性剂,用于开发揭示运动毒性机制的系统方法。将衍生具有不对称细胞动力学的体外人类细胞系,以提供可能与人类成体干细胞生理学具有更大相关性的运动毒性测定。这项研究的目的是为深入研究的环境污染物的致癌机制提供新的见解,这些污染物的作用方式仍然是个谜。这些见解将推动制定更好的策略,以限制与接触环境致癌物相关的发病率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES L SHERLEY其他文献
JAMES L SHERLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES L SHERLEY', 18)}}的其他基金
Increased Validation of a First Method for Counting Tissue Stem Cells Specifically
增强对组织干细胞特异性计数方法的验证
- 批准号:
10080303 - 财政年份:2020
- 资助金额:
$ 29.69万 - 项目类别:
Kinetotoxic Mechanisms of Environmental Carcinogens
环境致癌物的运动毒性机制
- 批准号:
7176921 - 财政年份:2004
- 资助金额:
$ 29.69万 - 项目类别:
Kinetotoxic Mechanisms of Environmental Carcinogens
环境致癌物的运动毒性机制
- 批准号:
6867323 - 财政年份:2004
- 资助金额:
$ 29.69万 - 项目类别:
Kinetotoxic Mechanisms of Environmental Carcinogens
环境致癌物的运动毒性机制
- 批准号:
7515339 - 财政年份:2004
- 资助金额:
$ 29.69万 - 项目类别:
相似国自然基金
LncRNA SFTA1P绑定TP53I3蛋白抑制多环芳烃类环境致癌物致肺遗传损伤和癌变的作用及机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长链非编码RNAABHD11-AS1通过miR-182-5p/Tiam1-Rac1轴介导烟草致癌物NNK诱导肺癌发生的作用与机制
- 批准号:82073579
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
Loc101928316介导Wnt通路在致癌物MNNG诱发胃癌中的作用机制研究
- 批准号:81803188
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
烟草特异亚硝胺致癌物在P450酶中的代谢活化及毒性作用机制研究
- 批准号:21707122
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
NOD2-RIPK2途径通过调节细胞自噬而促进化学物诱导的肺癌发生
- 批准号:81773055
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 29.69万 - 项目类别:
Targeting oncogenic pathways for chemoprevention of head and neck cancer by FLLL12
通过 FLLL12 靶向致癌途径对头颈癌进行化学预防
- 批准号:
10497514 - 财政年份:2023
- 资助金额:
$ 29.69万 - 项目类别:
CMA-Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Interception of tobacco smoking-related bladder cancer by an epigenetic approach
CMA-暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:通过表观遗传学方法拦截与吸烟相关的膀胱癌
- 批准号:
10260302 - 财政年份:2022
- 资助金额:
$ 29.69万 - 项目类别:
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
致癌过程中氧化应激相关危险因素的生物标志物、机制和调节
- 批准号:
10704632 - 财政年份:2022
- 资助金额:
$ 29.69万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10589966 - 财政年份:2022
- 资助金额:
$ 29.69万 - 项目类别: